PROSPECT MEDICAL CENTRE — All Prescriptions & Medications — Page 2
Practice Code: A86004 | NEWCASTLE UPON TYNE, NE4 8AY
Showing results 51-100 of 640
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Macrogol 3350 | 1,443 | 65.8K | £11.0K | +53.9% ▲ |
| Amoxicillin | 1,434 | 79.0K | £2.0K | +53.8% ▲ |
| Montelukast | 1,424 | 32.0K | £1.6K | +108.0% ▲ |
| Duloxetine hydrochloride | 1,408 | 38.5K | £2.7K | +121.5% ▲ |
| Isosorbide mononitrate | 1,360 | 50.0K | £3.4K | +105.8% ▲ |
| Hydrocortisone | 1,329 | 37.5K | £10.6K | +196.4% ▲ |
| Carbocisteine | 1,301 | 140.0K | £3.7K | +143.7% ▲ |
| Rosuvastatin calcium | 1,258 | 37.3K | £1.6K | +40.1% ▲ |
| Bendroflumethiazide | 1,247 | 45.0K | £751 | +61.2% ▲ |
| Diazepam | 1,215 | 38.2K | £2.4K | +143.9% ▲ |
| Quetiapine | 1,215 | 29.6K | £10.6K | +95.1% ▲ |
| Naproxen | 1,204 | 59.8K | £2.7K | +22.0% ▲ |
| 1,138 | 134.8K | £5.6K | +139.8% ▲ | |
| Prednisolone | 1,133 | 46.7K | £3.6K | +41.8% ▲ |
| Alginic acid compound preparations | 1,117 | 535.3K | £7.2K | +90.7% ▲ |
| Perindopril erbumine | 1,112 | 37.2K | £2.7K | +109.5% ▲ |
| Empagliflozin | 1,107 | 28.7K | £35.6K | +76.9% ▲ |
| Ferrous fumarate | 1,083 | 59.7K | £2.1K | +49.4% ▲ |
| Carbomer 940/980 | 1,072 | 26.0K | £5.6K | +604.0% ▲ |
| Ibuprofen | 1,068 | 81.0K | £1.9K | +110.0% ▲ |
| Spironolactone | 1,038 | 17.0K | £2.0K | +92.5% ▲ |
| Atenolol | 1,037 | 30.7K | £712 | +72.0% ▲ |
| Betamethasone valerate | 1,015 | 82.5K | £6.6K | +163.6% ▲ |
| Aripiprazole | 954 | 15.7K | £3.2K | +274.9% ▲ |
| 942 | 96.1K | £3.0K | +240.7% ▲ | |
| Fexofenadine hydrochloride | 930 | 32.6K | £1.4K | +9.4% ▲ |
| Levetiracetam | 912 | 46.2K | £2.3K | +99.2% ▲ |
| 880 | 25.4K | £9.2K | +32.5% ▲ | |
| Zopiclone | 879 | 11.2K | £513 | +58.7% ▲ |
| Cyanocobalamin | 871 | 35.1K | £4.8K | +146.7% ▲ |
| Sildenafil (Erectile Dysfunction) | 866 | 5,939 | £1.5K | +71.8% ▲ |
| Carbamazepine | 858 | 70.7K | £3.7K | +189.1% ▲ |
| 849 | 2,164 | £77.1K | +55.8% ▲ | |
| Finasteride | 839 | 14.7K | £572 | +28.1% ▲ |
| Rivaroxaban | 824 | 19.7K | £14.1K | +34.7% ▲ |
| Fluticasone/umeclidinium/vilanterol | 820 | 859 | £36.3K | +249.8% ▲ |
| Lercanidipine hydrochloride | 818 | 23.7K | £2.3K | +32.4% ▲ |
| Risperidone | 807 | 16.6K | £1.0K | +219.0% ▲ |
| Alendronic acid | 778 | 3,588 | £1.6K | +3.7% ▲ |
| Trazodone hydrochloride | 776 | 24.5K | £1.1K | +279.7% ▲ |
| Co-codamol (Codeine phosphate/paracetamol) | 765 | 83.1K | £3.5K | -60.9% ▼ |
| Doxycycline hyclate | 752 | 9,608 | £943 | +46.7% ▲ |
| Candesartan cilexetil | 720 | 18.5K | £855 | -39.3% ▼ |
| 709 | 7,995 | £2.9K | +239.2% ▲ | |
| Mirabegron | 692 | 15.4K | £14.2K | +72.3% ▲ |
| Flucloxacillin sodium | 690 | 39.4K | £1.9K | +53.4% ▲ |
| Hydroxocobalamin | 690 | 837 | £1.8K | +43.4% ▲ |
| Mometasone furoate | 686 | 723 | £5.6K | +70.9% ▲ |
| Famotidine | 683 | 14.2K | £7.8K | +40.0% ▲ |
| Indapamide | 668 | 21.4K | £1.2K | -22.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.